Skip to content
10-K

Annual Report

AGIOS PHARMACEUTICALS, INC. AGIO

0001439222-26-000025

← back to feed
Filed
Feb 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 6, 2026 58.59M sh
Shares Diluted FY 2025 · Dec 31, 2025 57.97M sh
Shares Diluted FY 2025 · Dec 31, 2024 57.89M sh
Shares Diluted FY 2025 · Dec 31, 2023 55.65M sh
Capex FY 2025 · Dec 31, 2025 $4.32M
Capex FY 2025 · Dec 31, 2024 $1.69M
Capex FY 2025 · Dec 31, 2023 $999K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$372.98M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$389.84M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$296.06M
Cash And Equivalents FY 2025 · Dec 31, 2025 $89.13M
Cash And Equivalents FY 2025 · Dec 31, 2024 $76.25M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.19B
Stockholders Equity FY 2025 · Dec 31, 2024 $1.54B
Stockholders Equity FY 2025 · Dec 31, 2023 $811.02M
Stockholders Equity FY 2025 · Dec 31, 2022 $1.1B
Current Liabilities FY 2025 · Dec 31, 2025 $82.21M
Current Liabilities FY 2025 · Dec 31, 2024 $81.16M
Total Liabilities FY 2025 · Dec 31, 2025 $104.11M
Total Liabilities FY 2025 · Dec 31, 2024 $122.24M
Current Assets FY 2025 · Dec 31, 2025 $942.05M
Current Assets FY 2025 · Dec 31, 2024 $965.6M
Total Assets FY 2025 · Dec 31, 2025 $1.3B
Total Assets FY 2025 · Dec 31, 2024 $1.66B
Eps Diluted FY 2025 · Dec 31, 2025 −$7.12
Eps Diluted FY 2025 · Dec 31, 2024 $11.64
Eps Diluted FY 2025 · Dec 31, 2023 −$6.33
Eps Basic FY 2025 · Dec 31, 2025 −$7.12
Eps Basic FY 2025 · Dec 31, 2024 $11.86
Eps Basic FY 2025 · Dec 31, 2023 −$6.33
Sga Expense FY 2025 · Dec 31, 2025 $180.28M
Sga Expense FY 2025 · Dec 31, 2024 $156.78M
Sga Expense FY 2025 · Dec 31, 2023 $119.9M
Rd Expense FY 2025 · Dec 31, 2025 $339.54M
Rd Expense FY 2025 · Dec 31, 2024 $301.29M
Rd Expense FY 2025 · Dec 31, 2023 $295.53M
Net Income FY 2025 · Dec 31, 2025 −$412.78M
Net Income FY 2025 · Dec 31, 2024 $673.73M
Net Income FY 2025 · Dec 31, 2023 −$352.09M
Operating Income FY 2025 · Dec 31, 2025 −$472.13M
Operating Income FY 2025 · Dec 31, 2024 −$425.74M
Operating Income FY 2025 · Dec 31, 2023 −$391.49M
Cost Of Revenue FY 2025 · Dec 31, 2025 $6.35M
Cost Of Revenue FY 2025 · Dec 31, 2024 $4.17M
Cost Of Revenue FY 2025 · Dec 31, 2023 $2.88M
Revenue FY 2025 · Dec 31, 2025 $54.03M
Revenue FY 2025 · Dec 31, 2024 $36.5M
Revenue FY 2025 · Dec 31, 2023 $26.82M